68 related articles for article (PubMed ID: 9808546)
21. Does hematopoietic stem cell transplantation benefit infants with acute leukemia?
Sison EA; Brown P
Hematology Am Soc Hematol Educ Program; 2013; 2013():601-4. PubMed ID: 24319238
[TBL] [Abstract][Full Text] [Related]
22. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
Mulder RL; van Dalen EC; Van den Hof M; Bresters D; Koot BG; Castellino SM; Loke Y; Leclercq E; Post PN; Caron HN; Postma A; Kremer LC
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD008205. PubMed ID: 21735424
[TBL] [Abstract][Full Text] [Related]
23. The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.
Dong L; Wu T; Gao ZY; Zhang MJ; Kan F; Spellman SR; Tan XY; Zhao YL; Wang JB; Lu DP; Miklos D; Petersdorf E; Fernandez-Vina M; Lee SJ
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1205-13. PubMed ID: 21193055
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell transplantation for leukemia.
Wayne AS; Baird K; Egeler RM
Pediatr Clin North Am; 2010 Feb; 57(1):1-25. PubMed ID: 20307709
[TBL] [Abstract][Full Text] [Related]
25. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia.
Nemecek ER; Gooley TA; Woolfrey AE; Carpenter PA; Matthews DC; Sanders JE
Bone Marrow Transplant; 2004 Nov; 34(9):799-806. PubMed ID: 15361903
[TBL] [Abstract][Full Text] [Related]
26. Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Greinix HT; Keil F; Brugger SA; Reiter E; Linkesch W; Lechner K; Schneider B; Dieckmann KU; Fischer G; Schwarzinger I; Haas O; Hinterberger W; Mannhalter C; Geissler K; Hocker P; Jager U; Kalhs P
Ann Hematol; 1996 Feb; 72(2):53-9. PubMed ID: 8597607
[TBL] [Abstract][Full Text] [Related]
27. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA
Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
[TBL] [Abstract][Full Text] [Related]
28. Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Gyurkocza B; Gutman J; Nemecek ER; Bar M; Milano F; Ramakrishnan A; Scott B; Fang M; Wood B; Pagel JM; Baumgart J; Delaney C; Maziarz RT; Sandmaier BM; Estey EH; Appelbaum FR; Storer BE; Deeg HJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):549-55. PubMed ID: 24440648
[TBL] [Abstract][Full Text] [Related]
29. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
Casper J; Camitta B; Truitt R; Baxter-Lowe LA; Bunin N; Lawton C; Murray K; Hunter J; Pietryga D; Garbrecht F
Blood; 1995 May; 85(9):2354-63. PubMed ID: 7727769
[TBL] [Abstract][Full Text] [Related]
30. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
[TBL] [Abstract][Full Text] [Related]
32. Haploidentical bone marrow transplants with post transplant cyclophosphamide on day + 3 + 5: The Genova protocol.
Raiola AM; Angelucci E; Sica S; Bacigalupo A
Blood Rev; 2023 Nov; 62():101031. PubMed ID: 36435691
[TBL] [Abstract][Full Text] [Related]
33. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Anderson JE; Gooley TA; Schoch G; Anasetti C; Bensinger WI; Clift RA; Hansen JA; Sanders JE; Storb R; Appelbaum FR
Blood; 1997 Apr; 89(7):2578-85. PubMed ID: 9116305
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
